ABVC BIOPHARMA, INC. UNDERWRITING AGREEMENT 1,100,000 Units Consisting of 1,100,000 Shares of Common Stock 1,100,000 Series A Warrants to Purchase 1,100,000 Shares of Common Stock And 1,100,000 Series B Warrants to Purchase 1,100,000 Shares of Common...Underwriting Agreement • August 5th, 2021 • Abvc Biopharma, Inc. • Pharmaceutical preparations • New York
ABVC BIOPHARMA, INC., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters,” or each, an “Underwriter”), for whom WallachBeth Capital, LLC is acting as representative (the “Representative”), an aggregate of 1,100,000 Units (the “Firm Units”), each Firm Unit consisting of (a) one share of the Company’s common stock, $0.001 par value per share (the “Common Stock”), (b) one Series A warrant (the “Series A Warrants”) to purchase one share of Common Stock and (c) one Series B warrant to purchase one share of common stock (the “Series B Warrants,” and together with the Series A Warrants, the “Warrants” and each a “Warrant”). The 1,100,000 shares of Common Stock referred to in this Section are hereinafter referred to as the “Firm Shares” and the Warrants referred to in this Section are hereinafter referred to as the “Firm Warrants,” and together with the Firm Uni
